134 related articles for article (PubMed ID: 25234005)
1. Design, synthesis, and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach.
Wang RB; Zhou W; Meng QQ; Zhang X; Ding J; Xu Y; Song HL; Yang K; Cui JH; Li SS
ChemMedChem; 2014 Dec; 9(12):2798-808. PubMed ID: 25234005
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
Wang R; Zhang X; Song H; Zhou S; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868
[TBL] [Abstract][Full Text] [Related]
3. Semi-synthesis and antitumor activity of 6-isomers of 5, 8-O-dimethyl acylshikonin derivatives.
Zhou W; Zhang X; Xiao L; Ding J; Liu QH; Li SS
Eur J Med Chem; 2011 Aug; 46(8):3420-7. PubMed ID: 21620530
[TBL] [Abstract][Full Text] [Related]
4. Advance in Anti-tumor Mechanisms of Shikonin, Alkannin and their Derivatives.
Zhang X; Cui JH; Meng QQ; Li SS; Zhou W; Xiao S
Mini Rev Med Chem; 2018; 18(2):164-172. PubMed ID: 28245783
[TBL] [Abstract][Full Text] [Related]
5. Semi-synthesis and anti-tumor activity of 5,8-O-dimethyl acylshikonin derivatives.
Zhou W; Peng Y; Li SS
Eur J Med Chem; 2010 Dec; 45(12):6005-11. PubMed ID: 20970893
[TBL] [Abstract][Full Text] [Related]
6. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
7. DMAKO-20 as a New Multitarget Anticancer Prodrug Activated by the Tumor Specific CYP1B1 Enzyme.
Cui J; Zhang X; Huang G; Zhang Q; Dong J; Sun G; Meng Q; Li S
Mol Pharm; 2019 Jan; 16(1):409-421. PubMed ID: 30481041
[TBL] [Abstract][Full Text] [Related]
8. Study on the enantiomeric ratio of the pharmaceutical substances alkannin and shikonin.
Assimopoulou AN; Papageorgiou VP
Biomed Chromatogr; 2004 Dec; 18(10):791-9. PubMed ID: 15386577
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of New Naphthalene and Naphthoquinone Derivatives as Anticancer Agents.
Beretta GL; Ribaudo G; Menegazzo I; Supino R; Capranico G; Zunino F; Zagotto G
Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 27990691
[TBL] [Abstract][Full Text] [Related]
10. Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
Valipour M
Eur J Med Chem; 2022 May; 235():114314. PubMed ID: 35367708
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity evaluations of albumin-binding prodrugs of CC-1065 analog.
Wang Y; Jiang J; Jiang X; Cai S; Han H; Li L; Tian Z; Jiang W; Zhang Z; Xiao Y; Wright SC; Larrick JW
Bioorg Med Chem; 2008 Jul; 16(13):6552-9. PubMed ID: 18508273
[TBL] [Abstract][Full Text] [Related]
12. Structure determination of oligomeric alkannin and shikonin derivatives.
Spyros A; Assimopoulou AN; Papageorgiou VP
Biomed Chromatogr; 2005 Sep; 19(7):498-505. PubMed ID: 15651092
[TBL] [Abstract][Full Text] [Related]
13. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.
Gong K; Li W
Free Radic Biol Med; 2011 Dec; 51(12):2259-71. PubMed ID: 22011623
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of heterocyclic carboxylic acyl shikonin derivatives.
Wang XM; Lin HY; Kong WY; Guo J; Shi J; Huang SC; Qi JL; Yang RW; Gu HW; Yang YH
Chem Biol Drug Des; 2014 Mar; 83(3):334-43. PubMed ID: 24118825
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanisms involved in the cytotoxicity of alkannin derivatives.
Wu HQ; Huang ZS; Bu XZ; Shen YD; Zhang ZL; Xie BF; Liu ZC; Gu LQ; Chan AS
Eur J Med Chem; 2005 Dec; 40(12):1341-5. PubMed ID: 15992967
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties and derivatives of shikonin-A review in recent years.
Guo C; He J; Song X; Tan L; Wang M; Jiang P; Li Y; Cao Z; Peng C
Pharmacol Res; 2019 Nov; 149():104463. PubMed ID: 31553936
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.
Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L
J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793
[TBL] [Abstract][Full Text] [Related]
18. Substituted 3‑acyl‑2‑phenylamino‑1,4‑naphthoquinones intercalate into DNA and cause genotoxicity through the increased generation of reactive oxygen species culminating in cell death.
Farias MS; Pich CT; Kviecinski MR; Bucker NC; Felipe KB; Da Silva FO; Günther TM; Correia JF; Ríos D; Benites J; Valderrama JA; Calderon PB; Pedrosa RC
Mol Med Rep; 2014 Jul; 10(1):405-10. PubMed ID: 24756411
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of shikonin, alkannin and their derivatives. II. X-ray analysis of cyclo-alkannin leucoacetate, tautomerism of alkannin and cyclo-alkannin and antitumor activity of alkannin derivatives.
Sankawa U; Otsuka H; Kataoka Y; Iitaka Y; Hoshi A; Kuretani K
Chem Pharm Bull (Tokyo); 1981 Jan; 29(1):116-22. PubMed ID: 7261189
[No Abstract] [Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of a Novel Water-soluble Prodrug of Docetaxel with Amino Acid as a Linker.
Ma H; Chen G; Wang T; Li Q; Liu Y
Chem Biol Drug Des; 2016 Sep; 88(3):363-9. PubMed ID: 27061863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
